Used in bioconjugation processes, particularly in the synthesis of antibody-drug conjugates (ADCs). Its structure enables selective attachment of cytotoxic agents to monoclonal antibodies through lysine residues, leveraging the active ester formed upon release of the 4-nitrophenol leaving group. The maleimide group (from the 2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl moiety) allows for subsequent conjugation to thiol groups on antibodies via Michael addition, ensuring stable and site-specific linkage. Commonly applied in pharmaceutical development for targeted cancer therapies where controlled drug delivery is critical. Also utilized in protein labeling and functionalization of biomolecules due to its dual reactivity and compatibility with aqueous-organic solvent systems.